<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136233">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01985880</url>
  </required_header>
  <id_info>
    <org_study_id>2013-0616</org_study_id>
    <nct_id>NCT01985880</nct_id>
  </id_info>
  <brief_title>The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome</brief_title>
  <official_title>Experimental Study of Biomarker in Patient With Interstitial Cystitis/Painful Bladder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate efficacy of biomarker in patient with interstitial
      cystitis/painful bladder syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a observational study
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>To compare of expression of the biomarker such as APF, HB-EGF, MCP-1 among the Hunner's ulcer interstitial cystitis and non-ulcer interstitial cystitis and control groups</measure>
    <time_frame>1month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>To compare of changes voiding parameters after bladder biopsy between Hunner' ulcer group and non-ulcer group</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TO compare of change of scores of questionnaires such as O'Leary-Sant Interstitial Cystitis questionnaire (IC-Q), Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF), Visual Analogue Scale (Pain) between Hunner's ulcer group and non-ulcer group</measure>
    <time_frame>1month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Interstitial Cystitis</condition>
  <arm_group>
    <arm_group_label>Hunner's ulcer interstitial cystitis</arm_group_label>
    <description>Hunner's ulcer interstitial cystitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-ulcer interstitial cystitis</arm_group_label>
    <description>non-ulcer interstitial cystitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Control</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      bladder biopsy, urine, blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients &gt;20 years old with interstitial cystitis control
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1)  must have experienced bladder pain, urinary urgency and urinary frequency, for at
             least 6 months prior to entry into the study 2) Pain VAS ≥4 3) O'Leary-Sant
             Interstitial Cystitis questionnaire (IC-Q) symptom and problem ≥ 12( and pain ≥2, and
             nocturia ≥ 2) 4) PUF score ≥ 13 5) cystoscopic record within 2 years

        Exclusion Criteria:

          1. Patients who are pregnancy or, childbearing age without no contraception

          2. Patients with voided volume &lt;40 or, &gt; 400ml

          3. Patients with microscopic hematuria, (≥1+ in dipstick), If not excluded that no
             evidence of neoplastic tumor examination

          4. Patients with urine culture showing evidence of urinary tract infection 1month prior
             to the study

          5. Accompanied medical problem below

               -  Tuberculosis in urinary system

               -  Bladder cancer, urethral cancer, prostate cancer

               -  Recurrent cystitis

               -  anatomical disorder

          6. Patients had prior surgery (eq, bladder augmentation, cystectomy

          7. Patients with neurologic disorder

          8. Patients with indwelling catheter or intermittent self-catheterization

          9. Patients with psychologic problem
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myung-Soo Choo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Myung-Soo Choo, M.D.</last_name>
    <phone>82-2-3010-3735</phone>
    <phone_ext>No</phone_ext>
    <email>mschoo@amc.seoul.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan medical center Institutional review board</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>82-2-3010-7166</phone>
      <phone_ext>No</phone_ext>
      <email>irb@amc.seoul.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>November 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Myung-Soo Choo</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cystitis</mesh_term>
    <mesh_term>Cystitis, Interstitial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
